BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 19581928)

  • 21. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
    van Nes JG; de Kruijf EM; Putter H; Faratian D; Munro A; Campbell F; Smit VT; Liefers GJ; Kuppen PJ; van de Velde CJ; Bartlett JM
    Breast Cancer Res Treat; 2012 May; 133(1):49-59. PubMed ID: 21796367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions.
    Elloul S; Vaksman O; Stavnes HT; Trope CG; Davidson B; Reich R
    Clin Exp Metastasis; 2010 Mar; 27(3):161-72. PubMed ID: 20213325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
    Zhou C; Nitschke AM; Xiong W; Zhang Q; Tang Y; Bloch M; Elliott S; Zhu Y; Bazzone L; Yu D; Weldon CB; Schiff R; McLachlan JA; Beckman BS; Wiese TE; Nephew KP; Shan B; Burow ME; Wang G
    Breast Cancer Res; 2008; 10(6):R105. PubMed ID: 19087274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.
    Yan W; Cao QJ; Arenas RB; Bentley B; Shao R
    J Biol Chem; 2010 Apr; 285(18):14042-51. PubMed ID: 20189993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition.
    Li S; Zhang J; Yang H; Wu C; Dang X; Liu Y
    Sci Rep; 2015 Jul; 5():12410. PubMed ID: 26174737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
    Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
    Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial-mesenchymal Transition (EMT) Markers in Human Pituitary Adenomas Indicate a Clinical Course.
    Jia W; Zhu J; Martin TA; Jiang A; Sanders AJ; Jiang WG
    Anticancer Res; 2015 May; 35(5):2635-43. PubMed ID: 25964539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
    Yang J; Mani SA; Donaher JL; Ramaswamy S; Itzykson RA; Come C; Savagner P; Gitelman I; Richardson A; Weinberg RA
    Cell; 2004 Jun; 117(7):927-39. PubMed ID: 15210113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer.
    Lundgren K; Nordenskjöld B; Landberg G
    Br J Cancer; 2009 Nov; 101(10):1769-81. PubMed ID: 19844232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression.
    Miura N; Yano T; Shoji F; Kawano D; Takenaka T; Ito K; Morodomi Y; Yoshino I; Maehara Y
    Anticancer Res; 2009 Oct; 29(10):4099-106. PubMed ID: 19846957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
    Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
    Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of heterogeneous Twist2 expression in human breast cancers.
    Mao Y; Zhang N; Xu J; Ding Z; Zong R; Liu Z
    PLoS One; 2012; 7(10):e48178. PubMed ID: 23133563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
    Kim J; Kong J; Chang H; Kim H; Kim A
    Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
    Nakajima S; Doi R; Toyoda E; Tsuji S; Wada M; Koizumi M; Tulachan SS; Ito D; Kami K; Mori T; Kawaguchi Y; Fujimoto K; Hosotani R; Imamura M
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4125-33. PubMed ID: 15217949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial-to-Mesenchymal Transition
    Liu LC; Wu YC; Kuo SC; Ho CT; Way TD; Chen ST
    Anticancer Res; 2018 May; 38(5):2849-2859. PubMed ID: 29715108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.